The next phase of enterprise AI

OpenAI outlines the next phase of enterprise AI, as adoption accelerates across industries with Frontier, ChatGPT Enterprise, Codex, and company-wide AI agents.

Life Bio’s Trial: Is the FDA Warming to Rejuvenation?

The FDA views aging as an inevitability, not a medical target. However, with Life Biosciences moving the first cellular reprogramming therapy into human trials this year, things might be changing there. If this technique works in resetting the biological age of the human eye, the entire multibillion-dollar longevity industry could move to the center of […]

The Timing of Meals Matters for Biological Aging

A recent study investigated a connection between the timing of meals and the rate of biological aging. These findings suggest that later timing of the first and last meals is associated with faster aging [1]. Finding the right patterns and rhythms Chrono-nutrition is an approach that connects eating patterns, circadian rhythms, and health outcomes [2]. […]

Introducing the Child Safety Blueprint

Discover OpenAI’s Child Safety Blueprint—a roadmap for building AI responsibly with safeguards, age-appropriate design, and collaboration to protect and empower young people online.